Toggle navigation
Home
Search
Services
Blog
Contact
About
Antibody-Drug Conjugate Therapy for Cancer Treatment
Chari, Ravi V.
Immunogen, Inc., Cambridge, MA, United States
Search 16 grants from Ravi Chari
Search grants from Immunogen, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Uncovering roles of metabolites in colorectal cancer etiology
Identifying and Addressing Patient and System Factors Associated with Racial and Ethnic Disparities in Care of Adults with Intellectual and Developmental Disabilities
The Role of LFA-1 in T Cell Activation
Isolation & Characterization of Lens Spectrin & Ankyrinn
Molecular Systematics of Homobasidiomycetes Emphasizing Polyporaceae and Corticiaceae
Recently added grants:
Statistical and high-throughput models of enhancer function and evolution
Microbiota-Dependent Control of Clostridium Difficile: the Role of Acetate and IL-22 Binding Protein
Cognitive training to reduce incidence of cognitive impairment in older adults
An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease
An expandable polymeric valved conduit to repair congenital heart disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44CA056209-02A3
Application #
2008020
Study Section
Special Emphasis Panel (ZRG2-SSS-4 (02))
Project Start
1992-07-01
Project End
1999-03-31
Budget Start
1997-07-11
Budget End
1998-03-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
Immunogen, Inc.
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Related projects
NIH 1998
R44 CA
Antibody-Drug Conjugate Therapy for Cancer Treatment
Chari, Ravi V. / Immunogen, Inc.
NIH 1997
R44 CA
Antibody-Drug Conjugate Therapy for Cancer Treatment
Chari, Ravi V. / Immunogen, Inc.
Publications
Xie, Hongsheng; Audette, Charlene; Hoffee, Mary et al.
(2004)
Pharmacokinetics and biodistribution of the antitumor immunoconjugate, cantuzumab mertansine (huC242-DM1), and its two components in mice.
J Pharmacol Exp Ther 308:1073-82
Comments
Be the first to comment on this grant